Tumours

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (19-23 October)

News round-up for 19-23 October 2026 by Megan Thomas, Multimedia Editor at DDW.  In this week’s news roundup, drug discovery and biopharma companies continue to make progress across the drug development pipeline, with recent updates highlighting clinical trial milestones, emerging research and investment in new treatments. The… Read More

#News

Skin cancer cells
#Cancer research #Cancer Research UK #Tumours #University College London

Clearing  ‘immune fog’ could stop lung cancer years before diagnosis 

Scientists funded by Cancer Research UK have discovered a “rising fog” that may cloud the immune system’s ability to detect tumours, potentially helping lung cancer develop years before diagnosis.  The team at University College London (UCL), led by Dr James Reading and Professor Sam Janes, were able… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Rare disease #Technology #Tumours

This week in Drug Discovery (12-16 October)

News round-up for 12-16 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as new initiatives to accelerate rare disease drug development, promising preclinical data for Duchenne muscular dystrophy, clinical trial… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (5-9 October 2026) 

News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (28 September – 2 October 2026) 

News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories:  In-person… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (21-25 September 2026) 

News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (14-18 September 2026) 

News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (31 August – 4 September 2026) 

News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (17-21 August 2026) 

News round-up for 17-21 August by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories:  DDII Digital Forum:… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (27-31 July 2026) 

News round-up for 27-31 July by Megan Thomas, Content Team at DDW.  This week’s news roundup centres around investment, innovation and strategic growth, which have dominated this week’s headlines. Across the drug discovery sector, companies have secured funding, expanded R&D capabilities and accelerated the adoption of AI-driven… Read More

#News

#Biotechnology #Cancer research #Drug discovery #Tumours

This week in Drug Discovery (20-24 July 2026) 

News round-up for 20-24 July by Megan Thomas, Content Team at DDW.  This week’s news roundup highlights the latest advances in cancer research and treatment, from promising clinical trial updates to discoveries that could improve the body’s immune response to tumours. The top stories include progress in… Read More

#News

Breast cancer cell
#Breast cancer #Cancer therapeutics #Clinical trials #Intensity Therapeutics #intratumoural cancer therapies #Tumours

Phase II triple-negative breast cancer trial restarts

Intensity Therapeutics has administered INT230-6 in the INVINCIBLE-4 Study in Switzerland. The clinical biotechnology company is focused on the discovery and development of novel intratumoural cancer therapies that are designed to kill tumours and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology. The trial (NCT06358573) analyses… Read More

#News

The tumour microenvironment
#Biotech #Cancer research #Tumours

Iksuda Therapeutics reveals positive data from IKS014 trial

Biotechnology company Iksuda Therapeutics has announced positive data from the Phase I study of IKS014 for the treatment of cancer patients with advanced HER2+ solid tumours.  IKS014, a human epidermal growth factor receptor 2 (HER2)-directed ADC, resulted in anti-tumour activity across all dose levels in various tumour… Read More

#News

Pancreatic cancer
#Cancer research #Pancreatic cancer #Tumours

Benzaldehyde halts the growth of pancreatic cancer

Researchers from Japan have shown that benzaldehyde, a compound responsible for the aroma of almonds, halts the growth and spread of therapy-resistant pancreatic cancer. By preventing various signalling proteins and histone modifiers like Ser28-phosphorylated histone H3 (H3S28ph) from binding to 14-3-3ζ protein, the study has shown that benzaldehyde overcomes therapy… Read More

#Cancer Research #News

#Cancer research #Drug development #Drug discovery #Immune system #Immunotherapy #Life sciences #Lithuania #Oncology #Start-ups #Tumour biology #Tumours

New podcast: Exciting start-ups and developments in drug discovery

This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘… Read More

#News